Our experience demonstrates that when trial volunteers—healthy or otherwise—are carefully managed during an early phase trial, the trial is more likely to meet its objectives in generating the necessary data to advance on to the next stage of development.
TORONTO (PRWEB) March 03, 2020
As with any other clinical study, the most important aspect of a Phase I trial is to identify participants and prepare them to fulfill study requirements. Therefore, significant consideration should be given towards the thoughtful management of trial volunteers during this phase of your program. Ultimately, however, the purpose of clinical research is to generate data that is as comprehensive as possible to provide evidence for claims, and this task needs to be prioritized as well.
By evaluating key areas of study design such as inclusion/exclusion criteria, procedural requirements, assessments to be performed, and inpatient vs. outpatient visit scheduling, we pose that early phase trials can not only be positioned for success in data generation and consumption but also create the baseline in ideas and activities that overcome challenges in volunteer recruitment and retention during the conduct for future studies.
Our experience demonstrates that when trial volunteers—healthy or otherwise—are carefully managed during an early phase trial, the trial is more likely to meet its objectives in generating the necessary data to advance on to the next stage of development. This not only involves educating volunteers and providing them with the necessary resources to participate in a study but understanding, managing and responding to their expectations when it comes to their participation.
Join this webinar on Tuesday, March 17, 2020 at 2pm EDT, to learn more about considerations and strategies for implementing a “volunteer-centric” approach in executing Phase I clinical trials which will increase your chances of success when recruiting and retaining trial participants and achieving a fully-completed clinical study without delay or interruption. As well as, discuss specific examples of how this type of approach was a crucial factor in achieving success during an early-stage trial.
Featured speakers will include:
- Talia Nikolao Hight, MBA, VP, Commercial Operations, WCCT Global
- Sammy Armado, Associate Director, Volunteer Recruitment & Engagement, WCCT Global
- David L. Wirta, MD, President and CEO, The Eye Research Foundation and The Aesthetic Eye Care Institute
For more information or to register for this event, visit Does Superior Volunteer Management Help Achieve Endpoints and Objectives in Phase I Trials? Three Experts Share Their Views.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.